Differentiation of the Cs in lung cancer: Cancer vs. COVID

The appendix reproduces a submission by the Clinical Expert Group for lung cancer and mesothelioma which includes recommendations about differentiation of symptoms from lung cancer from those due to COVID-19 and recommendations for easy access of patients with concerning symptoms for assessment by primary care.

Chair of the BTOG Board of Trustees and Consultant Thoracic Surgeon, John Edwards in conversation with Liz Darlison from Mesothelioma UK on the impact of COVID-19 on mesothelioma

Paper on Recommendation for Reduced Fractionation in Lung Cancer Patients Treated with Curative intent Radiotherapy during the COVID-19 Pandemic

The objectives of this paper are two-fold:

1) to identify reduced-fractionation and curative-intent radiotherapy regimes in lung cancer, assess their evidence base, and provide organs-at-risk dose constraints and

2) to discuss limitations and practical considerations associated with their implementation.

Summary of the Lung Radiotherapy during Coronavirus (COVID-RT Lung) national data collection initiative

Summary of the Lung Radiotherapy during Coronavirus (COVID-RT Lung) national data collection initiative (under the auspices of the NCRI CTRad COVID-RT national data collection). This project aims to assess the impact of our recommendations on practice and on the clinical outcome of lung cancer patients considered for radiotherapy in the UK during the pandemic